Clinical Trials on for Substance Abuse Treatment in Korea, Democratic People's Republic of
Total 11 results
-
Daewoong Pharmaceutical Co. LTD.CompletedTreatment for Submental FatKorea, Republic of
-
Inje UniversityCompleted
-
Dong-A Pharmaceutical Co., Ltd.CompletedHyperovulation Induction for Assisted Reproduction TreatmentKorea, Republic of
-
Samsung Medical CenterUnknownDepression | Adverse Reaction to Drug | Continuous Antidepressant AbuseKorea, Republic of
-
Samsung Medical CenterH. Lundbeck A/SUnknownDevelopment of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide ScanningDepression | Adverse Reaction to Drug | Continuous Antidepressant AbuseKorea, Republic of
-
Yonsei UniversityCanariaBio Inc.RecruitingPARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentKorea, Republic of
-
BayerRecruitingHemophilia A | Prophylaxis of Bleeding | Treatment of BleedingKorea, Republic of
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Yale UniversityNational Institute on Drug Abuse (NIDA)WithdrawnHIV Infections | Opiate DependenceUnited States, Iran, Islamic Republic of
-
Jaseng Hospital of Korean MedicineCompletedMusculoskeletal Diseases | Drug-Induced Liver InjuryKorea, Republic of
-
AmgenCompletedAny Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical TrialCanada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom